Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection
about
Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1betaGenetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV InfectionsRetroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of researchHigh avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral functionNatural truncation of the chemokine MIP-1 beta /CCL4 affects receptor specificity but not anti-HIV-1 activityIncreased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.Long-term changes of serum chemokine levels in vaccinated military personnelSelf-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.Induction of rapid and extensive beta-chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype.Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression.Human retroviruses after 20 years: a perspective from the past and prospects for their future control.Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1.Specific pathogen-free status alters immunophenotype in rhesus macaques: implications for the study of simian immunodeficiency virus.Control of HIV-1 infection by soluble factors of the immune response.Changes in B-Cell Counts and Percentages during Primary HIV Infection Associated with Disease Progression in HIV-Infected Men Who Have Sex with Men: A Preliminary StudyInitial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replicationSignificance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma.Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.Haplotype structure and linkage disequilibrium in chemokine and chemokine receptor genes.Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT(1A) receptorsSecretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usageHost CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women.Breast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission.The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitorsCharacterization of Simian Immunodeficiency Virus Variants Anatomically Compartmentalized in Plasma and Milk in Chronically Infected African Green MonkeysMendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.Platelet microbicidal protein 1: structural themes of a multifunctional antimicrobial peptide.Effector and regulatory roles for B cells in HIV infection?Association between ABCG2 Q141K polymorphism and gout risk affected by ethnicity and gender: a systematic review and meta-analysis.Induction of CC-chemokines with antiviral function in macrophages by the human T lymphotropic virus type 2 transactivating protein, Tax2Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopy.Immunological responses and viral modulatory effects of vaccination with recombinant modified vaccinia virus Ankara (rMVA) expressing structural and regulatory transgenes of simian immunodeficiency virus (SIVmac32H/J5M).Highly active antiretroviral therapy and beta-chemokines.Suppression of MIP-1beta transcription in human T cells is regulated by inducible cAMP early repressor (ICER).
P2860
Q24555821-4B54ACDD-165B-4E3E-9EEB-23B515B303BFQ26768628-87729B2B-DD96-4CA7-A08E-66C7A188CC45Q26853678-5243D5A1-94A5-49EA-AD40-2816E64492CAQ27323727-6CCAF7D9-556D-4231-AFAF-0569D47ED130Q28205217-AE116A0B-D0FC-4021-ABB4-47F385735C01Q30372415-32480B6C-C46B-4847-93E7-8D020C87E05CQ30427403-6E9CC556-DC58-47D7-9C0B-17F282CB253BQ33257138-39C2933D-FC79-4AF2-A263-A248C6CFEE14Q33378492-35613782-3E4B-410D-91A5-ED6584920508Q33848825-A77883E4-768F-49F7-8A07-FE86248C0C10Q34224950-C5563B95-57B1-437E-9E50-579716DF814FQ34389601-FBA21FAB-BC43-498D-973E-81B3D5D253E5Q34763384-48509574-FF28-4BD0-A25E-B9F1185E24F0Q34781801-86378291-1081-4CC7-BCAE-9C324B6B26F3Q34792498-C0F141AA-7F97-40AB-84DA-9345A96B6C57Q34922802-AE73EE67-EC0E-47CF-94B6-3B3C50814F7DQ35267854-5AD7516E-A82A-4202-86A5-099B773BD3CBQ35752416-C976CFDD-75E4-4335-AC1C-EEC562AF1781Q36075696-6B993B78-061F-4A87-B37E-206C25111B25Q36086631-DBC136EE-1CA1-462C-B3F3-91A67B1AE308Q36303451-437BC6F7-61FD-4B36-B3E9-453103CA6CCFQ36371505-C6263DEB-DEB4-4524-B42F-2B6DD90CA013Q36475185-5F9A3A13-62F3-4BA8-8533-E7B5FB629E73Q36735850-25EA6AF9-ABFE-4094-8D28-298ABFC3C167Q36738008-5FE0CD69-3F93-4A4F-8ECB-27484CE2921FQ36926499-9139CEF9-1FE8-4109-90DC-C51DEAC653C5Q37032208-3016EF71-0CCF-4472-BD3B-FB62984D503EQ37092774-2DCB644B-DF41-4E38-B509-25DDAB1AF1AEQ37252913-92388B52-3C11-4A7E-A6AA-5395C6B4EC3BQ37295610-DA51DB7E-5E75-4229-81CC-300D433065ADQ37598689-0300B20A-387F-4BD5-9888-81C72D6ED59CQ37997855-BAC80362-D464-4A42-BCF8-D41D5F902658Q38339494-9F800C62-07C3-4FC3-A2C8-23720EA72433Q39216919-07D4E2CD-1ECE-4DDC-98D1-53B78F85E5EDQ40705563-2CF86D24-068A-4C03-ABD6-72C937F3DD57Q40844843-C61FACD8-3CA9-4AD1-B9FC-402156F3BA09Q42510518-12F98B9E-DF87-4EF0-AD2F-E14D8117494EQ44581444-3C403D9B-D667-47DA-BF76-6F29299AA635Q44991108-C352B265-1C29-4701-81E6-6B0CCE73FEE3Q46917120-67BFDDA9-9AE2-4F0D-9F86-F4CB7870E6EE
P2860
Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Higher macrophage inflammatory ...... h asymptomatic HIV-1 infection
@ast
Higher macrophage inflammatory ...... h asymptomatic HIV-1 infection
@en
type
label
Higher macrophage inflammatory ...... h asymptomatic HIV-1 infection
@ast
Higher macrophage inflammatory ...... h asymptomatic HIV-1 infection
@en
prefLabel
Higher macrophage inflammatory ...... h asymptomatic HIV-1 infection
@ast
Higher macrophage inflammatory ...... h asymptomatic HIV-1 infection
@en
P2093
P2860
P356
P1476
Higher macrophage inflammatory ...... h asymptomatic HIV-1 infection
@en
P2093
A Garzino-Demo
A L DeVico
F Cleghorn
R Redfield
R Yarchoan
S Colombini-Hatch
W A Blattner
P2860
P304
13812-13817
P356
10.1073/PNAS.240469997
P407
P577
2000-12-01T00:00:00Z